Virginia Tech® home

A Ribocentric View of Muscle Proteostasis in Health and Disease: Novel Mechanisms Potential Therapeutic Opportunities

Insert your title here

Your Text Here
Gustavo Nader, Ph.D., FAPS headshot

Gustavo Nader, Ph.D., FAPS

Professor
College of Health and Human Development
Chair, Molecular, Cellular, and Integrative Physiology
Huck Institutes of the Life Sciences
The Pennsylvania State University
View Speaker Profile
Pioneers in Biomedical Research Seminar

A Ribocentric View of Muscle Proteostasis in Health and Disease: Novel Mechanisms Potential Therapeutic Opportunities

Date: Nov. 22, 2024

Time: 11 a.m. - 12 p.m.

Download Flyer

About this Seminar

Loss of skeletal muscle mass is associated with functional impairments, disability and increased mortality. Treatments to prevent muscle loss are an urgent unmet clinical need.  Therefore, understanding the mechanisms that regulate muscle mass will provide potential clinical targets to improve quality of life and survival of aged individuals, and those suffering from a wide variety of chronic disorders. In this seminar, Dr. Nader will present mechanistic evidence demonstrating that muscle anabolism is determined by the ability of the muscle to synthesize ribosomes. He will focus the discussion on the regulation of ribosomal DNA transcription by RNA Polymerase I and will provide evidence for a role of the mechanistic target of Rapamycin (mTOR) in both transcriptional and epigenetic regulation of rDNA genes. Dr. Nader will also discuss how alterations in proteostasis negatively impact rDNA transcription and muscle mass.

Additional Details

This is a free event hosted by the Fralin Biomedical Research Institute and co-sponsored by the institute's Center for Exercise Medicine Research. The Pioneers in Biomedical Research Seminar Series, which runs annually from September to May, has featured leading biomedical researchers from throughout the country since the program began in 2012. The lectures are also open to all members of the Virginia Tech community including graduate students, undergraduates, faculty, and staff, as well as the public.

You May Also Be Interested In...

  • Home Item
    Social Learning in Borderline Personality Disorder
    Social Learning in Borderline Personality Disorder , home

    April 4, 2025, 11:00 a.m. | Sarah Fineberg, M.D., Ph.D., Assistant Professor, Department of Psychiatry, Yale School of Medicine | Co-Sponsored by the Fralin Biomedical Research Institute Center for Human Neuroscience Research

  • Home Item
    Bringing Precision Medicine to Psychiatry
    Bringing Precision Medicine to Psychiatry , home

    April 10, 2025, 5:30 p.m. (Reception at 5 p.m.) | Jordan Smoller, M.D., Sc.D., MGH Trustees Endowed Chair in Psychiatric Neuroscience; Professor of Psychiatry, Harvard Medical School; Professor of Epidemiology, T.H. Chan Harvard School of Public Health; Director, Psychiatric and Neurodevelopmental Genetics Unit, Massachusetts General Hospital | Maury Strauss Distinguished Public Lecture

  • Home Item
    Extracellular Vesicles in the Pathogenesis, Diagnosis and Treatment of the Heart
    Extracellular Vesicles in the Pathogenesis, Diagnosis and Treatment of the Heart , home

    April 11, 2025, 11:00 a.m. | Susmita Sahoo, Ph.D., Associate Professor, Department of Medicine and Cardiology, Icahn School of Medicine at Mount Sinai | Co-Sponsored by the Fralin Biomedical Research Institute Center for Vascular and Heart Research

  • Home Item
    A Human-Centric View of Cerebellar Development
    A Human-Centric View of Cerebellar Development , home

    April 18, 2025, 11:00 a.m. | Kathleen Millen, Ph.D., Professor, Department of Pediatrics/Genetics, Associate Director and Principal Investigator, Seattle Children's Hospital Research Institute, The University of Washington School of Medicine | Co-Sponsored by the Center for Neurobiology Research, Fralin Biomedical Research Institute

  • Home Item
    Molecular and Neurobiological Studies in Rett Syndrome and Other MECP2 Disorders
    Molecular and Neurobiological Studies in Rett Syndrome and Other MECP2 Disorders , home

    May 1, 2025, 5:30 p.m. (Reception at 5 p.m.) | Huda Zoghbi, M.D., Professor, Pediatrics, Molecular and Human Genetics, Neuroscience, and Neurology; Director, Jan and Dan Duncan Neurological Research Institute, Baylor College of Medicine; Member, National Academy of Medicine | Maury Strauss Distinguished Public Lecture

  • Home Item
    A Novel Bispecific Antibody to Target the Brain Tumor Microenvironment
    A Novel Bispecific Antibody to Target the Brain Tumor Microenvironment , home

    May 2, 2025, 11:00 a.m. | Khuson Yun, Ph.D., Associate Professor, Department of Neurology, Houston Methodist Chair, Neurodegenerative Disease Research, Houston Methodist Research Institute, Weill Cornell Medical College | Co-Sponsored by the Fralin Biomedical Research Institute Cancer Research Center – Roanoke